𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Survival in patients with primary soft-tissue sarcomas treated within 6 years

✍ Scribed by M. Peiper; D. Zurakowski; R. Schwarz; H.-J. Weh; C. Zornig

Book ID
106124685
Publisher
Springer-Verlag
Year
1998
Tongue
English
Weight
417 KB
Volume
124
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Racial and ethnic differences in treatme
Racial and ethnic differences in treatment and survival among adults with primary extremity soft-tissue sarcoma
✍ Steve R. Martinez; Anthony S. Robbins; Frederick J. Meyers; Richard J. Bold; Vij πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 93 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Limb preservation is preferred to amputation for patients with extremity soft tissue sarcoma (ESTS). Disparities in the treatment and outcomes of several malignancies have been reported, but not for ESTS. The authors assessed racial/ethnic differences in patient‐ and tum

Phase II trial of cisplatin (CPDD) in pr
Phase II trial of cisplatin (CPDD) in previously treated patients with advanced soft tissue sarcoma
✍ Joseph Brenner; Gordon B. Magill; Peter P. Sordillo; Edgar W. Cheng; Allan Yagod πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 249 KB πŸ‘ 3 views

Thirty-six previously treated adult patients with advanced soft tissue sarcomas received CPDD 120 mg/m2 with mannitol diuresis. There were only two (6%) partial responses and five (15%) minor responses in 34 evaluable patients. Toxicity included nausea and vomiting, myelosuppression, mild ototoxicit